Microneedle skin patches
CeraVx is revolutionizing the administration of vaccines and therapeutics using microneedle skin patches to boost your immune system
About us
Never lose sight to administer more efficiently! CeraVx intradermal microneedle array patches are minimally invasive and thus pain free.
CeraVx is a privately held global biotechnology company developing and commercializing a proprietary drug delivery platform based on ceramic microneedle array patches (CeraMap). The CeraMaps platform can deliver a wide range of therapeutics and vaccines.
CeraVx’s accomplished team is made up of some of the biotech industry’s most experienced vaccine experts, united by a shared commitment to enhancing vaccine delivery in the most optimal way. Aimed at improving immune responses and ensuring the highest levels of efficiency for both the prevention and treatment of patients.
Our technology
CeraMaps are micrometre-scale microneedles made from biocompatible, inert ceramic materials, integrated into a patch designed for intradermal drug delivery. Each CeraMaps patch is completely inert and contains approximately one hundred microneedles, which only penetrate the outermost layer of the skin where abundant immune cells naturally reside.
- The needles do not reach sensitive nerves or blood vessels.
- Administration of vaccines or medicines is painless.
- Intradermal delivery requires 5 to 20 times less active compund
- No needle phobia
- Localised delivery
- Other applications: cosmetic, diagnostics
CeraMaps manufacturing
A Deep-Tech Platform customizable and scalable combining practices and equipment from two major industries:
- Micro-manufacturing and design from the Semi-Conductor industry
- Nano-pore ceramics from the Gas Separation industry
CeraMaps Microneedle Patches
CeraCore patches: have a surface topography with nanopores for fast drying at ambient temperature, tunable delivery with smaller and larger pores.
CeraShovel patches: High flexibility in formulation, excellent for larger particles and sharp needles convenience.
For (Bio)pharma
CeraVx is an agile and trusted microneedle company with proven expertise in research, pilot manufacturing and (pre) clinical studies. CeraMaps proprietary technology can be used for multiple indications ranging from vaccine drug delivery to diagnostics and biosensing.
We are open to partner with research centers and biopharma companies of all sizes to enable efficient, affordable research studies and clinical trial support to accelerate the microneedle technologies within the healthcare industry. Our inert ceramic sharp needle tips are compatible with many different vaccines, small molecule drugs, biologicals and nanoparticles allowing close to painless skin penetration
News
CeraVx’s team, Dinja Oosterhoff and Jan Groen will be at the WVC 2025 on April 21 – 24 In Washington DC. Visit them at booth S23.
CeraVx B.V. Emerges from Stealth Acquires Micro Needle Technology from MLT Appoints Management and Supervisory Board
Company Update Monday, 09 December 2024 04:00 AM CeraVx BV successful bid to acquire key micro needle technology from MLT Management team: Dr. Jan Groen as CEO, Dinja Oosterhof , PhD as Sr....
Leadership Team
Dr Jan Groen
Chief Executive Officer
Dinja Oosterhoff, PhD
Director R&D
Jelte Meulenaar, PharmD PhD
Chief Operating Officer
Supervisory Board
Bart van Zijl Langhout, PhD
Chairman
Ivo Ploemen, PhD
Non Executive Director
Join CeraVx
If you are fueled by passion to push the boundaries in vaccine and drug delivery then you could be the candidate we are looking for. Located in the heart of vaccine research in Leiden Life Science Park , the Netherlands